-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Background: Some people worry that the new coronary pneumonia pandemic disrupts patients' access to medical care and access to medical care, and affects the diagnosis and management of other diseases such as cancer
After 2021, the incidence of cancer in adults has dropped by 50%
Results: The quarterly age-standardized incidence rates of COVID-19 were 157.
Table 1 Results of the intervention autoregressive integrated moving average model, which summarizes the association between the COVID-19 pandemic and the monthly age-standardized incidence rate of new pediatric cancer diagnoses per million population
Table 1 Results of the intervention autoregressive integrated moving average model, which summarizes the association between the COVID-19 pandemic and the monthly age-standardized incidence rate of new pediatric cancer diagnoses per million populationFigure 1 Observation and prediction of the monthly age-standardized incidence rate (ASIRs) of newly diagnosed cancers per million children, overall and stratified by cancer type: A) all cancers combined, B) leukemia and lymphoma, C) central nervous system tumors And D) Extracranial solid tumors
Figure 1 Observation and prediction of the monthly age-standardized incidence rate (ASIRs) of newly diagnosed cancers per million children, overall and stratified by cancer type: A) all cancers combined, B) leukemia and lymphoma, C) central nervous system tumors And D) Extracranial solid tumors
Figure 2 Monthly age-standardized incidence rates (ASIRs) per million of all childhood cancers observed and predicted by geographic region: A) Atlantic Province (Nova Scotia, Prince Edward Island, New Brunswick, Newfoundland) And Labrador), B) Quebec, C) Ontario, D) Prairie Province (Manitoba, Saskatchewan and Alberta) and E) British Columbia
Figure 2 Monthly age-standardized incidence rates (ASIRs) per million of all childhood cancers observed and predicted by geographic region: A) Atlantic Province (Nova Scotia, Prince Edward Island, New Brunswick, Newfoundland) And Labrador), B) Quebec, C) Ontario, D) Prairie Province (Manitoba, Saskatchewan and Alberta) and E) British Columbia
Table 2 The proportion of children who participated in clinical trials who had metastatic disease at the time of cancer diagnosis and died within 30 days
Table 2 The proportion of children who participated in clinical trials who had metastatic disease at the time of cancer diagnosis and died within 30 daysConclusion: During the first 9 months of the COVID-19 pandemic, we did not observe a statistically significant change in the incidence of childhood cancer or the proportion of children who participated in clinical trials, showed metastatic disease or died prematurely.
During the first 9 months of the COVID-19 pandemic, we did not observe a statistically significant change in the incidence of childhood cancer or the proportion of children who participated in clinical trials, showed metastatic disease or died prematurely, the report shows , In Canada, the chances of childhood cancer patients' access to medical care have not been significantly reduced
Pelland-Marcotte MC, Xie L, Barber R, Elkhalifa S,et al.
Incidence of childhood cancer in Canada during the COVID-19 pandemic.
Leave a message here
